Growth Hormone / Endocrine
Education on hormone signaling, growth hormone pathways, endocrine function, and metabolic regulation.
GHRP-6
Synthetic hexapeptide growth hormone secretagogue acting through the ghrelin receptor, studied for pituitary GH release, appetite signaling, and endocrine response.
IGF-1 LR3
Modified IGF-1 analog (Long R3) with reduced IGF-binding protein affinity, studied for IGF-1 receptor signaling, nutrient uptake, and tissue remodeling.
Sermorelin
Synthetic 29 amino acid GHRH analog studied for pituitary growth hormone release, endocrine signaling, and age-associated GH decline.
Tesamorelin
FDA-approved GHRH analog (EGRIFTA WR), studied for pituitary GH release and clinically used to reduce visceral abdominal fat in HIV-associated lipodystrophy.
Ipamorelin
Synthetic pentapeptide growth hormone secretagogue, selective GH release via the ghrelin receptor with less ACTH/cortisol response than older GHRPs.
Tesamorelin / Ipamorelin
Dual-pathway GH signaling blend pairing a GHRH analog (Tesamorelin) with a selective ghrelin-receptor secretagogue (Ipamorelin) for combined endogenous GH release research.
CJC-1295 No DAC / Ipamorelin
Dual-pathway GH signaling blend pairing a short-acting GHRH analog (CJC-1295 No DAC) with a selective ghrelin-receptor secretagogue (Ipamorelin) for pulse-oriented endogenous GH release research.